Literature DB >> 18448374

Partial trypsin digestion as an indicator of mis-folding of mutant alanine:glyoxylate aminotransferase and chaperone effects of specific ligands. Study of a spectrum of missense mutants.

M B Coulter-Mackie1, Q Lian.   

Abstract

Alanine:glyoxylate aminotransferase (AGT) is a liver peroxisomal enzyme whose deficiency results in primary hyperoxaluria type 1 (PH1). More than 75 PH1 mutations are now documented in the AGT gene (AGXT), of which about 50% are missense. We have previously demonstrated that many such mutants expressed by transcription/translation are subject to generalized degradation by the proteasome and a specific limited trimming by an endogenous ATP-independent protease activity. Here, we report the results of partial digestion using trypsin as a mimic for the endogenous non-proteasomal protease and the use of N-terminal protein sequencing to determine the sensitive site. Partial trypsin digestion also provided an indicator of proper folding of the mutant enzyme. For selected mutations the sensitivity to trypsin could be ameliorated by addition of pyridoxal phosphate or aminooxy acetic acid as specific pharmacological chaperones.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448374     DOI: 10.1016/j.ymgme.2008.03.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  12 in total

1.  Cystathionine beta-synthase mutants exhibit changes in protein unfolding: conformational analysis of misfolded variants in crude cell extracts.

Authors:  Aleš Hnízda; Vojtěch Jurga; Kateřina Raková; Viktor Kožich
Journal:  J Inherit Metab Dis       Date:  2011-11-09       Impact factor: 4.982

2.  Membrane-enabled dimerization of the intrinsically disordered cytoplasmic domain of ADAM10.

Authors:  Wei Deng; Sungyun Cho; Pin-Chuan Su; Bryan W Berger; Renhao Li
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

3.  Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate.

Authors:  Petra Melenovská; Jana Kopecká; Jakub Krijt; Aleš Hnízda; Kateřina Raková; Miroslav Janošík; Bridget Wilcken; Viktor Kožich
Journal:  J Inherit Metab Dis       Date:  2014-10-21       Impact factor: 4.982

4.  Effects of alanine:glyoxylate aminotransferase variants and pyridoxine sensitivity on oxalate metabolism in a cell-based cytotoxicity assay.

Authors:  Sonia Fargue; John Knight; Ross P Holmes; Gill Rumsby; Christopher J Danpure
Journal:  Biochim Biophys Acta       Date:  2016-02-06

5.  Molecular defects of the glycine 41 variants of alanine glyoxylate aminotransferase associated with primary hyperoxaluria type I.

Authors:  Barbara Cellini; Riccardo Montioli; Alessandro Paiardini; Antonio Lorenzetto; Fabio Maset; Tiziana Bellini; Elisa Oppici; Carla Borri Voltattorni
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.

Authors:  Barbara Cellini; Riccardo Montioli; Alessandro Paiardini; Antonio Lorenzetto; Carla Borri Voltattorni
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

7.  Molecular analysis of the AGXT gene in Syrian patients suspected with primary hyperoxaluria type 1.

Authors:  Hossam Murad; Mohamad Baseel Alhalabi; Amir Dabboul; Nour Alfakseh; Mohamad Sayah Nweder; Youssef Zghib; Hala Wannous
Journal:  BMC Med Genomics       Date:  2021-06-03       Impact factor: 3.063

8.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

Review 9.  Protein homeostasis defects of alanine-glyoxylate aminotransferase: new therapeutic strategies in primary hyperoxaluria type I.

Authors:  Angel L Pey; Armando Albert; Eduardo Salido
Journal:  Biomed Res Int       Date:  2013-07-16       Impact factor: 3.411

10.  Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.

Authors:  Elisa Oppici; Krisztian Fodor; Alessandro Paiardini; Chris Williams; Carla Borri Voltattorni; Matthias Wilmanns; Barbara Cellini
Journal:  Proteins       Date:  2013-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.